Fluconazole impacts the extracellular matrix of fluconazole-susceptible and-resistant Candida albicans and Candida glabrata biofilms

被引:29
作者
Dias Panariello, Beatriz Helena [1 ]
Klein, Marlise, I [2 ]
De Oliveira Mima, Ewerton Garcia [2 ]
Pavarina, Ana Claudia [2 ]
机构
[1] Indiana Univ Purdue Univ, Sch Dent, Dept Cariol Operat Dent & Dent Publ Hlth, Indianapolis, IN 46202 USA
[2] Sao Paulo State Univ, Sch Dent, Dept Dent Mat & Prosthodont, Unesp, Araraquara, SP, Brazil
来源
JOURNAL OF ORAL MICROBIOLOGY | 2018年 / 10卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
Biofilm; Candida albicans; Candida glabrata; extracellular matrix; fluconazole; fluconazole-resistant; IN-VITRO SUSCEPTIBILITY; DRUG-RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; TRANSCRIPTIONAL RESPONSE; STAPHYLOCOCCUS-AUREUS; AZOLE RESISTANCE; SPP; ITRACONAZOLE; QUANTITATION; INFECTIONS;
D O I
10.1080/20002297.2018.1476644
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Fluconazole (FLZ) is a drug commonly used for the treatment of Candida infections. However, -glucans in the extracellular matrices (ECMs) hinder FLZ penetration into Candida biofilms, while extracellular DNA (eDNA) contributes to the biofilm architecture and resistance. Methods: This study characterized biofilms of FLZ-sensitive (S) and -resistant (R) Candida albicans and Candida glabrata in the presence or absence of FLZ focusing on the ECM traits. Biofilms of C albicans American Type Culture Collection (ATCC) 90028 (CaS), C. albicans ATCC 96901 (CaR), C. glabrata ATCC 2001 (CgS), and C. glabrata ATCC 200918 (CgR) were grown in RPM! medium with or without FLZ at 5x the minimum inhibitory concentration (37 degrees C/48 h). Biofilms were assessed by colony-forming unit (CFU)/mL, biomass, and ECM components (alkali-soluble polysaccharides [ASP], water-soluble polysaccharides [WSP], eDNA, and proteins). Scanning electron microscopy (SEM) was also performed. Data were analyzed by parametric and nonparametric tests (a = 0.05). Results: In biofilms, FLZ reduced the CFU/mL of all strains (p < 0.001), except for CaS (p = 0.937). However, the ASP quantity in CaS was significantly reduced by FLZ (p = 0.034), while the drug had no effect on the ASP levels in other strains (p > 0.05). Total biomasses and WSP were significantly reduced by FLZ in the ECM of all yeasts (p < 0.001), but levels of eDNA and proteins were unaffected (p > 0.05). FLZ affected the cell morphology and biofilm structure by hindering hyphae formation in CaS and CaR biofilms, by decreasing the number of cells in CgS and CgR biofilms, and by yielding sparsely spaced cell agglomerates on the substrate. Conclusion: FLZ impacts biofilms of C. albicans and C. glabrata as evident by reduced biomass. This reduced biomass coincided with lowered cell numbers and quantity of WSPs. Hyphal production by C. albicans was also reduced.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Effects of Antifungal Agents Alone and in Combination Against Candida glabrata Strains Susceptible or Resistant to Fluconazole
    Alves, Izabel Almeida
    Bandeira, Laissa Arevalo
    Nunes Mario, Debora Alves
    Denardi, Laura Bedin
    Neves, Louise Vignoles
    Santurio, Janio Morais
    Alves, Sydney Hartz
    MYCOPATHOLOGIA, 2012, 174 (03) : 215 - 221
  • [32] Comparative in Vitro Activity of Voriconazole and Itraconazole Against Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida Species from Spain
    M. Cuenca-Estrella
    T. M. Díaz-Guerra
    E. Mellado
    A. Monzón
    J. L. Rodríguez-Tudela
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 432 - 435
  • [33] Determination of the effect of fluconazole against Candida albicans and Candida glabrata by using microbroth kinetic assay
    Kaya, Esma
    Ozbilge, Hatice
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (02) : 325 - 328
  • [34] The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole
    Borecka-Melkusova, Silvia
    Moran, Gary P.
    Sullivan, Derek J.
    Kucharikova, Sona
    Chorvat, Dusan, Jr.
    Bujdakova, Helena
    MYCOSES, 2009, 52 (02) : 118 - 128
  • [35] Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans
    Goetz, MB
    AIDS, 1996, 10 (03) : 335 - 336
  • [36] The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
    Li, Liping
    Zhang, Teng
    Xu, Jianrong
    Wu, Jing
    Wang, Yida
    Qiu, Xiran
    Zhang, Yu
    Hou, Weitong
    Yan, Lan
    An, Maomao
    Jiang, Yuanying
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [37] Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates
    Naidu, AS
    Fowler, RS
    Martinez, C
    Chen, J
    Tulpinski, J
    JOURNAL OF REPRODUCTIVE MEDICINE, 2004, 49 (10) : 800 - 807
  • [38] Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans
    Han, Bing
    Chen, Jia
    Yu, Yi-qun
    Cao, Yong-bing
    Jiang, Yuan-ying
    MICROBIOLOGY AND IMMUNOLOGY, 2016, 60 (02) : 82 - 92
  • [39] Proteomic analysis of fluconazole resistance in Candida albicans
    Wang, Zhiyuan
    Zhang, Gehua
    Zhang, Xiaoli
    Wu, Si
    Yin, Xingfeng
    Zhang, Hong
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (16): : 1226 - 1230
  • [40] Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates
    Schulz, Bettina
    Knobloch, Mathias
    Weber, Kai
    Ruhnke, Markus
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 (03) : 155 - 161